Q2 2019 13F Detailed Holdings
-
Location
-
Kuesnacht, Switzerland
-
Holdings as of
-
6/30/2019
-
Value ($000)
-
$5,856,751
-
Num holdings
-
219
-
Date filed
-
8/14/2019
-
Form type
-
13F-HR
-
Note
-
Holdings broken out by “other managers” reported in original SEC filing,
see here
for holdings aggregated across other managers
| Sym |
Issuer Name |
Cl |
CUSIP |
Value ($000) |
% |
Shares |
Principal |
Option Type |
Discretion |
Other Manager |
Sole |
Shared |
None |
Other Managers
| Num |
Name |
File Number |
| 1 |
BB Biotech AG |
28-06964 |
| 2 |
Biotech Focus N V |
28-11193 |
| 3 |
Biotech Invest N V |
28-11191 |
| 4 |
Biotech Target N V |
28-11189 |
| 5 |
Biotech Growth N V |
28-11194 |
| 6 |
Bellevue Asset Management AG |
28-16892 |